State Street’s Inovio Pharmaceuticals INO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $436K | Buy |
|
|||||
|
2025
Q2 | $252K | Sell |
|
|||||
|
2025
Q1 | $838K | Buy |
|
|||||
|
2024
Q4 | $923K | Buy |
|
|||||
|
2024
Q3 | $2.84M | Buy |
|
|||||
|
2024
Q2 | $3.55M | Buy |
|
|||||
|
2024
Q1 | $1.23M | Buy |
|
|||||
|
2023
Q4 | $444K | Hold |
|
|||||
|
2023
Q3 | $339K | Sell |
|
|||||
|
2023
Q2 | $392K | Sell |
|
|||||
|
2023
Q1 | $22.9M | Sell |
|
|||||
|
2022
Q4 | $49.1M | Buy |
|
|||||
|
2022
Q3 | $44.9M | Sell |
|
|||||
|
2022
Q2 | $55.7M | Buy |
|
|||||
|
2022
Q1 | $83.5M | Buy |
|
|||||
|
2021
Q4 | $66.4M | Buy |
|
|||||
|
2021
Q3 | $78.4M | Buy |
|
|||||
|
2021
Q2 | $82.6M | Buy |
|
|||||
|
2021
Q1 | $76.6M | Sell |
|
|||||
|
2020
Q4 | $78.7M | Buy |
|
|||||
|
2020
Q3 | $92.8M | Buy |
|
|||||
|
2020
Q2 | $191M | Buy |
|
|||||
|
2020
Q1 | $12.9M | Buy |
|
|||||
|
2019
Q4 | $5.23M | Sell |
|
|||||
|
2019
Q3 | $3.58M | Buy |
|
|||||
|
2019
Q2 | $5.11M | Sell |
|
|||||
|
2019
Q1 | $15.6M | Buy |
|
|||||
|
2018
Q4 | $13.5M | Buy |
|
|||||
|
2018
Q3 | $17.1M | Sell |
|
|||||
|
2018
Q2 | $15.4M | Sell |
|
|||||
|
2018
Q1 | $21.1M | Buy |
|
|||||
|
2017
Q4 | $16.6M | Buy |
|
|||||
|
2017
Q3 | $23.8M | Buy |
|
|||||
|
2017
Q2 | $17M | Sell |
|
|||||
|
2017
Q1 | $16.6M | Sell |
|
|||||
|
2016
Q4 | $17.7M | Sell |
|
|||||
|
2016
Q3 | $27.8M | Buy |
|
|||||
|
2016
Q2 | $23.2M | Buy |
|
|||||
|
2016
Q1 | $18M | Sell |
|
|||||
|
2015
Q4 | $16.4M | Sell |
|
|||||
|
2015
Q3 | $25.6M | Buy |
|
|||||
|
2015
Q2 | $32.7M | Sell |
|
|||||
|
2015
Q1 | $33.2M | Buy |
|
|||||
|
2014
Q4 | $26.7M | Buy |
|
|||||
|
2014
Q3 | $23.1M | Buy |
|
|||||
|
2014
Q2 | $24.8M | Buy |
|
|||||
|
2014
Q1 | $17.1M | Sell |
|
|||||
|
2013
Q4 | $21.7M | Buy |
|
|||||
|
2013
Q3 | $252K | Buy |
|
|||||
|
2013
Q2 | $42K | Buy |
|